Nisin-based topical formulation for treatment of anthrax

Information

  • Research Project
  • 6665141
  • ApplicationId
    6665141
  • Core Project Number
    U01AI053860
  • Full Project Number
    5U01AI053860-02
  • Serial Number
    53860
  • FOA Number
    PAR-02-026
  • Sub Project Id
  • Project Start Date
    9/30/2002 - 21 years ago
  • Project End Date
    8/31/2006 - 18 years ago
  • Program Officer Name
    ZOU, LANLING
  • Budget Start Date
    9/1/2003 - 21 years ago
  • Budget End Date
    8/31/2006 - 18 years ago
  • Fiscal Year
    2003
  • Support Year
    2
  • Suffix
  • Award Notice Date
    9/10/2003 - 21 years ago
Organizations

Nisin-based topical formulation for treatment of anthrax

[unreadable] DESCRIPTION (provided by applicant): We propose to develop and produce a formulation, based on the antimicrobial peptide nisin, that is safe for use on human skin and rapidly bactericidal for vegetative cells and spores of the microbial pathogen Bacillus anthracis, the agent responsible for anthrax. The final product is intended for topical use as a decontaminant and disinfectant by military personnel, civilian victims, first-responders, and medical personnel exposed to B. anthracis in a biowarfare or bioterrorism attack. The project will build on the existing knowledge and technology surrounding nisin and its applications in the food industry to control food-spoilage organisms, including the outgrowth of spores of Bacillus spp. and Clostridium spp. and in the veterinary field as a topical sanitizer targeting Gram-positive and Gram-negative pathogens. Formulation development will combine nisin with chelators, non-ionic surfactants, and essential oils that have been shown to enhance nisin activity against Gram-negative and Gram-positive bacteria, including spores. Prototype formulations tested will include lotions, moist wipes, and creams. Testing will be conducted in the presence and absence of serum, using in vitro assays and in vivo animal topical infection models. The final product is intended to minimize the danger for those exposed to B. anthracis and should also be effective for disinfection of other bioterrorism agents and for nosocomial pathogens in the healthcare setting. [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    U01
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    388596
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    856
  • Ed Inst. Type
  • Funding ICs
    NIAID:388596\
  • Funding Mechanism
  • Study Section
    ZAI1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BIOSYNEXUS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    GAITHERSBURG
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    20877
  • Organization District
    UNITED STATES